Relating the Global Burden of Disease to Life Cycles

Bo Pedersen Weidema*, Peter Fantke

*Corresponding author for this work

    Research output: Contribution to journalConference articleResearchpeer-review

    150 Downloads (Pure)


    The Global Burden of Disease (GBD) study for the year 2016 reports a global disease burden of 0.32 DALY/person-year, given in disability-specific DALYs per country for 188 countries. However, the human health impacts from all LCIA categories included in the ReCiPe global normalisation reference for the year 2012 together account for <0.02 DALY/person-year. The difference of 0.30 DALY/person-year represents mortality and morbidity that to a large extent are caused by human activities and for which we identify the corresponding elementary flows and unit processes that should be included in product life cycle inventories. In total, we attribute 37% of the GBD to one or more of 79 specific risk factors (e.g. air pollution or dietary risks). The remaining GBD, not attributable to specified risk factors, we then divide in two parts: The ‘Unavoidable GBD’ (19%) and the residual (44%) that we find attributable to an ‘insufficient health care system’.
    Original languageEnglish
    JournalProcedia CIRP
    Pages (from-to)417-422
    Publication statusPublished - 2018
    Event25th CIRP Life Cycle Engineering (LCE) Conference - Copenhagen, Denmark
    Duration: 30 Apr 20182 May 2018
    Conference number: 25


    Conference25th CIRP Life Cycle Engineering (LCE) Conference
    Internet address

    Fingerprint Dive into the research topics of 'Relating the Global Burden of Disease to Life Cycles'. Together they form a unique fingerprint.

    Cite this